Extrait

The primary objectives of this study are to evaluate the efficacy of extended-release paliperidone (paliperidone ER) compared with placebo in the prevention of the recurrence of any mood symptoms (i.e., manic or depressive) associated with Bipolar I Disorder and to assess the safety and tolerability of paliperidone ER in subjects who maintain clinical stability after an acute manic or mixed episode.

Critère d'inclusion

• Bipolar I disorder, most recent maniac or mixed episode

Liens

• ictrp
• euctr